Medindia LOGIN REGISTER
Medindia
Advertisement

Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc

Thursday, February 14, 2008 General News
Advertisement
WALTHAM, Mass., Feb. 13 Inverness MedicalInnovations (Amex: IMA) today announced that its previously announcedacquisition of BBI Holdings Plc was successfully completed on February 12,2008. BBI, located in the United Kingdom, specializes in the development andmanufacture of non-invasive lateral flow tests and has achieved a globalreputation for manufacturing superior quality gold reagents. The finalpurchase price consisted of cash of approximately pounds Sterling 63.2million, or approximately $123.2 million, and approximately 251,300 shares ofInverness common stock. In addition, existing options to purchase BBI stockhave been assumed and have converted into options to purchase approximately360,000 shares of Inverness common stock.
Advertisement

For additional information on BBI, please visit www.bbigold.com

About Inverness

By developing new capabilities in near-patient diagnosis, monitoring andhealth management, Inverness Medical Innovations enables individuals to takecharge of improving their health and quality of life. A global leader inrapid point-of-care diagnostics, Inverness' products, as well as its newproduct development efforts, focus on infectious disease, cardiology,oncology, drugs of abuse and women's health. Inverness is headquartered inWaltham, Massachusetts. For additional information on Inverness MedicalInnovations, please visit www.invernessmedical.com.

SOURCE Inverness Medical Innovations
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close